Key result
Sleep-disordered breathing is detected in ~96% of ICD patients, mostly in moderate to severe forms.
Why the study?
The diagnostic efficacy of screening methods for sleep-disordered breathing, including questionnaires, overnight pulse oximetry, and ICD-embedded apnea detection algorithms, needed evaluation in patients with ICDs.
Do screening methods such as questionnaires, pulse oximetry, and ICD algorithms accurately detect sleep-disordered breathing compared to cardiorespiratory monitoring in patients with ICDs?
Do screening methods such as questionnaires, pulse oximetry, and ICD algorithms accurately detect sleep-disordered breathing compared to cardiorespiratory monitoring in patients with ICDs?
In patients with ICDs, sleep-disordered breathing is highly prevalent (95.5%), and computer-based pulse oximetry is a highly sensitive screening tool, whereas STOP-BANG and ESS questionnaires are unreliable.
High SDB prevalence in ICD patients supports screening awareness; leaves open prospective validation of tools before practice change.
Objective. To assess diagnostic efficacy of screening methods for sleep-disordered breathing — questionnaires (assessing the risk of obstructive sleep apnea and daytime sleepiness), overnight pulse oximetry and apnea detection algorithm embedded in implantable cardioverter-defibrillators (ICDs) in patients with ICDs. Material and methods. The study included 67 patients aged 34-83 years (median 65). There were 54 (81%) men, median body mass index was 29.4 kg/m2. All patients underwent CRM to detect sleep-disordered breathing. Screening performance of various diagnostic methods for sleep apnea detection was assessed in 39 patients using STOP-Bang questionnaire and Epworth Sleepiness Scale (ESS), in 20 patients — using computer-based pulse oximetry (PO), in 7 patients — via interpretation of respiratory disturbance index obtained from ICDs of specific models. Results of these screening methods were compared with CRM data. Results. According to CRM data, sleep-disordered breathing was detected in 64 (95.5%) patients (mild in 23 (34.5%), moderate in 22 (33%), and severe in 19 (28%) cases). In all cases, sleep-disordered breathing was obstructive, but 19 (28%) patients had combination with significant (more than 5 events/hour) episodes of central apnea. Compared to CRM data, sensitivity of STOP-BANG questionnaire in diagnosis of sleep-disordered breathing was 92% (specificity 33%). Sensitivity of ESS was 44%. Sensitivity of computer-based pulse oximetry for detecting sleep-disordered breathing was 100%. In 3 cases, computer-based pulse oximetry substantially underestimated severity of sleep-disordered breathing compared to CRM. Overestimation was noted in other 3 cases. In all 7 patients in whom respiratory disturbance indices were obtained from ICDs, mean overnight values indicated sleep-disordered breathing that was confirmed by CRM. In 3 patients with mild SDB confirmed by CRM, apnea detection algorithm in ICD markedly overestimated respiratory event index. Conclusion. In patients with ICDs, SDB is diagnosed in 95.5% of cases with moderate-to-severe forms identified in 61% patients. Compared to CRM data, STOP-BANG and ESS scales in patients with ICDs are not reliable in identifying SDB and cannot be recommended as the main screening methods. High sensitivity of computer-based pulse oximetry in detecting SDB, when compared with CRM data, supports recommendation of this method for screening in patients with ICDs.
No takes yet. Share an insight, caveat, or question.
Ksanaev et al. (2025) studied this question. In patients with implantable cardioverter-defibrillators, sleep-disordered breathing was detected in 95.5%, with 61% having moderate-to-severe forms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: